Vazkepa, known generically as icosapent ethyl, is a prescription medication primarily used to reduce the risk of cardiovascular events in adults with elevated triglyceride levels, specifically those with levels above 150 mg/dL. It is derived from highly purified eicosapentaenoic acid (EPA), an omega-3 fatty acid found in fish oil. Vazkepa works by helping to lower triglyceride levels in the bloodstream, which, in high levels, are associated with an increased risk of heart disease and stroke. It is often prescribed in conjunction with dietary changes and other medications to manage triglyceride levels effectively and improve cardiovascular health. Vazkepa has been rigorously tested in clinical trials and has shown significant benefits in reducing the risk of major adverse cardiovascular events, making it a valuable option for patients at risk of heart disease due to high triglyceride levels.